| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Athira Pharma, Inc. | Chief Financial Officer | Common Stock | 12,857 | $88,456 | $6.88 | 02 Jan 2026 | Direct |
| Athira Pharma, Inc. | Chief Financial Officer | Restricted Stock Units | 0 | $21,914 | $0.5619 | 31 Dec 2025 | Direct |
| Athira Pharma, Inc. | Chief Financial Officer | Stock Option (Right to Buy) | 34,358 | 24 Dec 2025 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| ATHA | Athira Pharma, Inc. | 31 Dec 2025 | 4 | +$267 | 4 | Chief Financial Officer | 05 Jan 2026, 19:50 |
| ATHA | Athira Pharma, Inc. | 24 Dec 2025 | 1 | $0 | 4 | Chief Financial Officer | 29 Dec 2025, 16:19 |
| ATHA | Athira Pharma, Inc. | 30 Jun 2025 | 4 | +$1,462 | 4 | SVP, Finance and Accounting | 02 Jul 2025, 16:32 |
| ATHA | Athira Pharma, Inc. | 03 Mar 2025 | 1 | $0 | 4/A | SVP, Finance and Accounting | 12 Mar 2025, 17:20 |
| ATHA | Athira Pharma, Inc. | 31 Dec 2024 | 4 | +$389 | 4 | VP of Finance | 03 Jan 2025, 17:01 |
| ATHA | Athira Pharma, Inc. | 01 Oct 2024 | 2 | $0 | 4 | VP of Finance | 03 Oct 2024, 19:17 |
| ATHA | Athira Pharma, Inc. | 01 Oct 2024 | 0 | $0 | 3 | VP of Finance | 03 Oct 2024, 19:05 |